Is RVPH or SCYX more undervalued in 2026?

CirclFi compares Reviva Pharmaceuticals Holdings (RVPH) and SCYNEXIS, Inc. (SCYX) using 13 institutional-grade valuation models. RVPH has a Quality of Company score of 3.7/10 while SCYX scores 5.6/10.

Which is a better buy — RVPH or SCYX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RVPH and SCYX valuations compare?

RVPH at $0.40 and SCYX at $0.70 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RVPH vs SCYX Valuation Comparison 2026 — Intrinsic Value Analysis

RVPH

Pharmaceutical Preparations

Reviva Pharmaceuticals Holdings

Quality

3.7

out of 10

Value Trap

SAFE

Price

$0.40

Last close

Models

5/13

Active

SCYX

Pharmaceutical Preparations

SCYNEXIS, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$0.70

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	RVPH Fair Value	RVPH Upside	SCYX Fair Value	SCYX Upside
Bayesian DCF	Intrinsic	$1.02	+153.9%	$0.38	-46.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.03	-96.6%	$0.06	-93.5%
Dynamic NAV	Asset-Based	—	—	$0.84	+19.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RVPH vs SCYX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RVPH vs SCYX — Which Stock Is More Undervalued?

SCYX scores higher with a 5.6/10 quality rating vs RVPH's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Reviva Pharmaceuticals Holdings (RVPH) and SCYNEXIS, Inc. (SCYX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RVPH currently trades at $0.40 with a QOC of 3.7/10, while SCYX trades at $0.70 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).